Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ezetimibe (zetia) (1 trial)
lomitapide (juxtapid) (1 trial)
Hypercholesterolemia (Phase 2)
Trials (1 total)
Trial APIs (2 total)